What is Biohaven's additional paid-in capital?

Biohaven (BHVN) reported additional paid-in capital of $203.36M in Q1 2026.

How has Biohaven's additional paid-in capital changed year-over-year?

Biohaven's additional paid-in capital increased by 47.9% year-over-year, from $137.47M to $203.36M.

What does additional paid-in capital mean?

Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.

Biohaven BHVN Additional Paid-In Capital

Additional Paid-In Capital at other companies

Eli LillyLLY

$6.92B+0.2%

Xenon PharmaceuticalsXENE

$264.88M+27.1%

Rapport Therapeutics, Inc.RAPP

$727.05M+67.6%

Vir Biotechnology, Inc.VIR

$2.14B+11.1%

uniQureQURE

$1.59B+26.2%

Roivant SciencesROIV

$5.02B+10.1%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's additional paid-in capital?: Biohaven (BHVN) reported additional paid-in capital of $203.36M in Q1 2026.
How has Biohaven's additional paid-in capital changed year-over-year?: Biohaven's additional paid-in capital increased by 47.9% year-over-year, from $137.47M to $203.36M.
What does additional paid-in capital mean?: Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.